Oklahoma State University Center for Health Sciences
Oklahoma State University Center for Health Sciences

News Alert:

Department of Pediatrics

Faculty and Staff

Amanda G. Foster, D.O., F.A.C.O.P.
Clinical Assistant Professor of Pediatrics

amanda.foster@okstate.edu

Employment | Education | Training, Experience and Skills | Licensure and Certification |Research | Professional Organizations | Presentations

 


Employment

July 2006 to present
Clinical Assistant Professor of Pediatrics
OSU Physicians 
Department of Pediatrics

 

Education

D.O.
Oklahoma State University C.O.M.
Tulsa, OK
1999-2003

B.S.
Oklahoma State University
Stillwater, OK
1997-1999

University of Oklahoma
Norman, OK
1995-1997


Training, Experience and Skills

2003-2006
Fast-Track Resident, OSU Pediatrics
Tulsa Regional Medical Center
Tulsa, OK

2004-2005
Resident representative, Board of Trustees
American College of Osteopathic Pediatricians

2005
OMECO delegate and ACOP representative, 5th Annual Congress of Interns and Residents

2004
OMECO delegate, 4th Annual Congress of Interns and Residents

Skills

Advanced Life Support Training   certified through 
Advanced Cardiac Life Support  2009
Pediatric Advanced Life Support 2009
Basic Life Support 2009
Neonatal Resuscitation 2009

Medical Spanish Course 2005-2006
Electronic Health Records 2004-2006
Proficient with computer—Microsoft products, Internet use, multimedia presentations, modern telemedicine technology 1999-present   


Licensure and Certification

2004-2009
Osteopathic Physician, Oklahoma

2006
Board Certified, American Osteopathic Board of Pediatrics

 

Research

Medimmune Protocol MI-CP150 2009
Subinvestigator; An expanded phase 1/2a randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, immunogenicity, and viral shedding of  MEDI-560, a live attenuated recombinant parainfluenza virus type 3 (PIV3) vaccine, administered intranasally to health infants 1 to <12 months of age

GSK Protocol MMRV-054 PRI 2008
Subinvestigator; A phase 2, randomized, observer blind, multicenter study of GlaxoSmithKline biologicals combined MMRV versus ProQuad, according to a one dose schedule, both administered SC at 12-14 months of age, concomitantly with Hepatitis A vaccine and pneumococcal conjugate vaccine but at separate sites

Wyeth protocol 6096A1-3005 2007-2009
Subinvestigator; A phase 3, randomized, double blinded trial evaluating safety, tolerability, and immunogenecity of 3 lots of 13-valent pneumococcal conjugate vaccine in health infants with routine pediatric vaccinations in the United States      

GSK protocol 103813/105067 -009 and -010 2007-2008
Subinvestigator; A phase 3, randomized, multinational study, double-blinded for immunogenicity and consistency evaluation of 3 Hib-MenCY-TT vaccine lots and single-blinded and controlled for the evaluation of safety and immunogenecity of GSK biologicals’ Haemophilus influenzae type b and Neisseria meningitis serogroups C and Y-tetanus toxoid conjugate vaccine combined compared to monovalent Hib vaccine in 2, 4, 6, and 12-15 months of age

Merck Protocol 067 2006-2008
Subinvestigator; An open, randomized, multicenter study of the safety, tolerability, and immunogenicity of VAQTA given concomitantly with Proquad and Prevnar in 
healthy children 12 months of age

Merck Protcol 068 2008-2009
Subinvestigator; An open, randomized, multicenter study of the safety, tolerability, and immunogenicity of VAQTA given concomitantly with PedvaxHIB and Infanrix in Healthy Children 15 months of age           

Sanofi protocol MTA44 2006-2008
Subinvestigator; An immunogenecity and safety evaluation of two doses of Menactra (Meningococcal Groups A, C, Y, and W-135 polysaccharide diphtheria toxoid conjugate vaccine) given to healthy subjects at 9 and 12 months of age         

Astellas Protocol: APPLES study 2006-2009
Subinvestigator; A prospective pediatric longitudinal evaluation to assess the long-term safety of Tacrolimus ointment for the treatment of atopic dermatitis

Influenza immunization study 2005-2006
Subinvestigator; Investigating the safety and effectiveness of the influenza vaccine in infants less than 6 months of age

Rotavirus immunization study 2003-2004
Subinvestigator; Investigated the safety and effectiveness of the rotavirus vaccine in infants               

          

Professional Organizations

American College of Osteopathic Pediatrician 2000-2009 
Resident member of Board of Trustees  2004-2005
Member of Student Chapter of ACOP at OSU-COM  2002-2004 
President of Student Chapter of ACOP at OSU-COM 2001-2002 
Secretary/Treasurer of Student Chapter of ACOP at OSU-COM 2000-2001
American Osteopathic Association 1999-2009
Oklahoma Osteopathic Association 2006-2009
American Academy of Pediatrics  2003-2006
Osteopathic Founders Association  2003-2006
Student Osteopathic Medical Association 1999-2003
Secretary OSU-COM chapter 2000-2001
Student Ambassador OSU-COM 1999-2003

Activities

Medical student interviews for admission into OSU-CHS 2008-2009
Bylaws committee at OSU Medical Center 2008-2009


Presentations

In-service to ancillary staff on pelvic exams/pap smears 2008

Case presentation and topic review on Protein C and S Deficiencies at the American Osteopathic Association National Convention 2004

Poster presentation on Protein C and S Deficiencies at the American Osteopathic Association National Convention2004

Case presentation and topic review on Allergic Rhinitis to OSU-COM medical students in their Immunology class 2004                               

Informal lectures to medical students, interns, residents on various topics, including Seizures in the Pediatric Population, Infants of Drug Abusing Mothers, Persistent Pulmonary Hypertension of the Newborn, Necrotizing Enterocolitis, Type I Distal Renal Tubular Acidosis, Medical Documentation, TheWell Child Check 2003-2009

 

 

OSU-CHS on Facebook OSU-CHS on Twitter OSU-CHS on Foursquare OSU Medicine on YouTube Google+